Reply: could late enhancement and need for permanent pacemaker implantation in patients undergoing TAVR be explained by undiagnosed transthyretin cardiac amyloidosis?

Siontis, George; Windecker, Stephan (2015). Reply: could late enhancement and need for permanent pacemaker implantation in patients undergoing TAVR be explained by undiagnosed transthyretin cardiac amyloidosis? Journal of the American College of Cardiology, 65(3), p. 313. Elsevier 10.1016/j.jacc.2014.10.037

[img] Text
1-s2.0-S0735109714069435-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (83kB) | Request a copy

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Windecker, Stephan

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0735-1097

Publisher:

Elsevier

Language:

English

Submitter:

Judith Liniger

Date Deposited:

25 Feb 2016 08:56

Last Modified:

26 Feb 2016 10:11

Publisher DOI:

10.1016/j.jacc.2014.10.037

PubMed ID:

25614435

BORIS DOI:

10.7892/boris.75950

URI:

https://boris.unibe.ch/id/eprint/75950

Actions (login required)

Edit item Edit item
Provide Feedback